Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc. et al

Filing 177

Attachment 2
OPENING CLAIM CONSTRUCTION BRIEF filed by Board of Trustees of the Leland Stanford Junior University. (Attachments: # 1 Appendix # 2 Proposed Order)(Rhyu, Michelle) (Filed on 8/10/2007) Modified on 8/13/2007 (gba, COURT STAFF).

Download PDF
Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems, Inc. et al Doc. 177 Att. 2 Case 3:05-cv-04158-MHP Document 177-3 Filed 08/10/2007 Page 1 of 2 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 COOLEY GODWARD KRONISH LLP A T T O R N E Y S A T LAW PALO A L T O COOLEY GODWARD KRONISH LLP STEPHEN C. NEAL (No. 170085) (nealsc@cooley.com) RICARDO RODRIGUEZ (No. 173003) (rr@cooley.com) MICHELLE S. RHYU (No. 212922) (mrhyu@cooley.com) Five Palo Alto Square 3000 El Camino Real Palo Alto, CA 94306-2155 Tel: (650) 843-5000 Fax: (650) 857-0663 Attorneys for Plaintiff and Counterclaim Defendant THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY and Counterclaim Defendants THOMAS MERIGAN and MARK HOLODNIY UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, Plaintiff, v. ROCHE MOLECULAR SYSTEMS, ET AL., Defendants. ROCHE MOLECULAR SYSTEMS, ET AL., Counterclaimants, v. THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY; THOMAS MERIGAN; AND MARK HOLODNIY, Counterclaim Defendants. Case No. C 05 04158 MHP [PROPOSED] ORDER RE CLAIM CONSTRUCTION Date: October 3, 2007 Courtroom: 15, 18th Floor Hon. Marilyn Hall Patel [PROPOSED] ORDER RE CLAIM CONSTRUCTION CASE NO. C 05 04158 MHP Dockets.Justia.com Case 3:05-cv-04158-MHP Document 177-3 Filed 08/10/2007 Page 2 of 2 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 COOLEY GODWARD KRONISH LLP A T T O R N E Y S A T LAW PALO A L T O On October 3, 2007, the Court held a hearing on claim construction by Plaintiff The Board of Trustees of the Leland Stanford Junior University ("Stanford") and Defendants Roche Molecular Systems et al. ("Roche"). Upon full consideration of all submitted papers and oral arguments in support of and in opposition to the claim construction, and for good cause shown, the Court construes the disputed terms as follows: Disputed Terms "therapeutically effective" "therapeutically ineffective" "an antiretroviral agent" Stanford's Construction No construction necessary No construction necessary "at least one substance having or capable of having an effect against a retrovirus, such as HIV" No construction necessary No construction necessary No construction necessary "gathering data from the patient and/or other sources that is useful in assessing whether any decline in HIV RNA copy number was not the result of chance" No separate construction necessary "a decrease that is large enough, by itself or when compared to other data, that it was not likely the result of chance" "measuring the HIV RNA copy number" "presence of detectable HIV-encoding nucleic acid" "absence of detectable HIV-encoding nucleic acid" "collecting statistically significant data useful for determining whether a decline in HIV RNA copy numbers exists" "statistically significant data" "statistically significant decline" SO ORDERED. Dated: Hon. Marilyn Hall Patel United States District Court Judge 1. [PROPOSED] ORDER RE CLAIM CONSTRUCTION CASE NO. C 05 04158 MHP

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?